Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 4 of 35

RECRUITING Phase 2

Bumetanide in Patients With Alzheimer's Disease

NCT06052163

RECRUITING NA

Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa

NCT05563649

RECRUITING NA

Electrical Stimulation for the Treatment of Glaucoma

NCT05626491

RECRUITING NA

Electrical Stimulation for the Treatment of Optic Neuropathies

NCT05626426

RECRUITING NA

Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep

NCT05413928

RECRUITING Phase 2

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

NCT04930887

RECRUITING Phase 3

Descemet Endothelial Thickness Comparison Trial II

NCT05275972

RECRUITING NA

Platelet Rich Plasma Testis Treatment for Infertile Men

NCT05479474

RECRUITING NA

Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

NCT05612750

RECRUITING NA

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder

NCT05849402

RECRUITING Phase 1

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

NCT05188170

RECRUITING NA

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

NCT05283564

RECRUITING NA

Hyperbaric Oxygen Therapy for Optic Neuropathies

NCT06128720

RECRUITING NA

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

NCT04899544

RECRUITING NA

The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia

NCT05379673

RECRUITING NA

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

NCT05415007

RECRUITING

Evaluating Pulse Oximetry Bias in Children With Darker Skin Pigmentation

NCT05617547

RECRUITING NA

Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making

NCT07035418

RECRUITING Phase 3

Pediatric Dose Optimization for Seizures in Emergency Medical Services

NCT05121324

RECRUITING NA

Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension

NCT05394766

RECRUITING Phase 1

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis

NCT04929951

RECRUITING NA

Comparing Operative vs Non Operative Treatment for Pilonidal Disease

NCT05439291

RECRUITING Phase 1

B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

NCT05474378

RECRUITING NA

Shifting Sleep Timing in Teens

NCT05808179

RECRUITING NA

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

NCT05297734

RECRUITING NA

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

NCT05365646

RECRUITING

StrokeCog-BBB to Study Cognitive Outcomes Following Stroke

NCT06116630

RECRUITING NA

Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders

NCT03918577

RECRUITING Phase 1

Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment

NCT04571203

RECRUITING Phase 4

Stanford Pragmatic Effectiveness Comparison

NCT04441034

RECRUITING Phase 1

Topical Insulin for Glaucoma

NCT05206877

RECRUITING NA

Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

NCT05206942

RECRUITING Phase 2

Limiting AAA With Metformin (LIMIT) Trial

NCT04500756

RECRUITING Phase 2

Study of Dextromethorphan in OCD and Related Disorders

NCT04899687

RECRUITING Phase 2

Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

NCT04676802

RECRUITING Early Phase 1

Study Comparing Local/ MAC Anesthesia in Lumbar Decompression

NCT04992572

RECRUITING NA

Decreasing Emergence Agitation With Personalized Music

NCT05044832

RECRUITING NA

CYP2C19 Variants and Limonene Metabolism

NCT05078723

RECRUITING NA

LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

NCT05366699

RECRUITING Phase 1

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

NCT05088356

RECRUITING NA

Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia

NCT04100057

RECRUITING Phase 1

Understanding Ketamine's Dissociative Effects (KD Study)

NCT04861051

RECRUITING NA

External Device for Erectile Dysfunction (3D-Erect)

NCT04624126

RECRUITING NA

Closed-loop Optimized rTMS for Depression

NCT04142320

RECRUITING Phase 2

Efficacy of Nitrous Oxide in OCD: Pilot Study

NCT03826693

RECRUITING Phase 2

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

NCT04585477

RECRUITING Phase 1

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

NCT04609592

RECRUITING Phase 1

d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC

NCT04392622

RECRUITING Phase 2

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose

NCT04278898

RECRUITING Phase 2

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

NCT04768426

← Previous Page 4 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.